Table 3 The mean and standard deviation (SD) or prevalence of the demographic variables of the study subjects
Females | Males | Gender difference | All | |
|---|---|---|---|---|
N = 16 | N = 16 | p-value (df) | N = 32 | |
Age, years (SD) | 39 (10.6) | 39 (8.4) | 0.956 (30)* | 39 (9.4) |
Height, cm (SD) | 164 (5.0) | 169 (41.9) | 0.637 (30)* | 167 (29.4) |
Weight, Kg (SD) | 63.2 (9.6) | 82.8 (12.4) | < 0.001 (29)* | 72.7 (14.7) |
Body mass index, Kg/m2 (SD) | 23.4 (3.3) | 25.6 (2.8) | 0.053 (29)* | 24.5 (3.2) |
TS pain, months (SD) | 24.1 (52.4) | 20.6 (37.9) | 0.827 (30)* | 22.4 (45.0) |
VAS, mm (SD) | 29.1 (22.9) | 24.7 (19.2) | 0.558 (30)* | 26.9 (20.9) |
R-MDQ, points (SD) | 2.1 (1.8) | 2.4 (2.5) | 0.689 (30)* | 2.3 (2.2) |
NSPD, points (SD) | 316 (211) | 291 (217) | 0.738 (30)* | 303 (211) |
Smoking, % (N) | 12.5 (2) | 12.5 (2) | 1.000 (1)§ | 12.5 (4) |
Physician consultation, % (N) | 43.8 (7) | 56.3 (9) | 0.724 (1)§ | 50.0 (16) |
Pain medication for TSP, % (N) | 18.8 (3) | 6.3 (1) | 0.600 (1)§ | 12.5 (4) |
Earlier MT intervention, % (N) | 87.5 (14) | 93.8 (15) | 1.000 (1)§ | 90.6 (29) |
Systemic disease# % (N) | 12.5 (2) | 25.0 (4) | 0.654 (1)§ | 18.8 (6) |